Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nathanael Gray
AddedMar 31, 2024
UpdatedMay 31, 2026
Nathanael Gray

Nathanael Gray

Board Member, C4 Therapeutics

Crunchbase

Nathanael Gray's Career

C4 Therapeutics
C4 Therapeutics

Cambridge, MA, US

Board Member· Board
Syros Pharmaceuticals
Syros Pharmaceuticals

Cambridge, MA, US

Board Member· Board
Petra Pharma
Petra Pharma

New York City, NY, US

Co-Founder
Soltego
Soltego

Newport Beach, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nathanael Gray's Career

C4 Therapeutics
C4 Therapeutics
Public$298.8M1462015Cambridge, MA, US
Board Member· Board

Leadership at C4 Therapeutics

Utpal KoppikarUtpal KoppikarBoard Member
Hagop YoussoufianHagop YoussoufianBoard Member
Marc CohenMarc CohenBoard Member
Andrew HirschAndrew HirschCEO
Ken AndersonKen AndersonCo-Founder
Bruce DowneyBruce DowneyBoard Member
Syros Pharmaceuticals
Syros Pharmaceuticals
Public$620.5M1172011Cambridge, MA, US
Board Member· Board

Leadership at Syros Pharmaceuticals

Conley CheeConley CheeCEO
James BradnerJames BradnerCo-Founder
Richard YoungRichard YoungBoard Member
Peter WirthPeter WirthBoard Member
Marsha FanucciMarsha FanucciBoard Member
Andy OhAndy OhBoard Member
Petra Pharma
Petra Pharma
Series B$75.5M302016New York City, NY, US
Co-Founder

Leadership at Petra Pharma

Lewis CantleyLewis CantleyCo-Founder
Soltego
Soltego
Series A$6.7M92017Newport Beach, CA, US
Board Member· Board

Leadership at Soltego

Irina ErenburgIrina ErenburgBoard Member
David FisherDavid FisherCo-Founder
Philippe SchaisonPhilippe SchaisonBoard Member

Similar to Soltego

OneSkinOneSkinSan Francisco, CA, USSkincare Productsest. 2016OneSkinSan Francisco, CA, US · est. 2016

OneSkin Technologies: A biotech platform focused on skin-health and longevity science.

Seed · $19.6M14
Siolta TherapeuticsSiolta TherapeuticsSan Carlos, CA, USBiotherapeutics, Diagnosticsest. 2016Siolta TherapeuticsSan Carlos, CA, US · est. 2016

Siolta Therapeutics: A venture-backed biotech firm innovating in inflammatory disease prevention.

Series C · $30M36
Soleno TherapeuticsSoleno TherapeuticsRedwood City, CA, USTherapeuticsest. 1999Soleno TherapeuticsRedwood City, CA, US · est. 1999

US-based Soleno Therapeutics develops and commercializes novel treatments for rare diseases.

Public · $160.5M25
Naked BiomeNaked BiomeCacheu Region, GWTherapeuticsest. 2015Naked BiomeCacheu Region, GW · est. 2015

Naked Biome: A therapeutics company advancing microbiome-based treatments for skin diseases.

Seed · $11.1M1

Nathanael Gray's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Nathanael Gray

Roy H. PerlisRoy H. PerlisCo-Founder · Psy TherapeuticsAlan AshworthAlan AshworthBoard Member · Tango TherapeuticsNicholas TheodoreNicholas TheodoreCo-Founder · Spine AlignTobias HanrathTobias HanrathCo-Founder · Dimensional EnergyPhilip KantoffPhilip KantoffBoard Member · Memorial Sloan Kettering Cancer CenterNathan PriceNathan PriceCo-Founder · Arivale